Medical devices, healthcare technology and the business of care
510(k) clearance · K260682

Bond-PR Universal Adhesive

Premier Dental Products Company · Decision date Mar 3, 2026

FDA DECISIONK260682

What did the FDA decide?

FDA records K260682 as a 510(k) premarket notification, with a decision dated Mar 3, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Mar 3, 2026

FDA source record

Regulatory record facts

Identifier
K260682
Regulatory pathway
510(k) premarket notification
Product code
KLE
Decision code
SESE
Decision date
Mar 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, Tooth Bonding, Resin.

Product code
KLE
FDA device class
2

FDA decision timeline

  1. K260682 received

    Application receipt date recorded by FDA.

  2. K260682 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KLE

Product / regulatory recordCompanyPathwayDecision dateSource
Dent4You AG510(k) clearanceOct 8, 2026FDA
Den-Mat Holdings, LLC510(k) clearanceSep 24, 2026FDA
Any-EtchK260485
Mediclus Co., Ltd.510(k) clearanceMay 14, 2026FDA
Belport Company, Inc., Gingi-Pak510(k) clearanceApr 10, 2026FDA
Adhese 2K252450
Ivoclar Vivadent, Inc.510(k) clearanceMar 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Premier Dental Products Company

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Plymouth Meeting, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records